SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.
HealthStream Inc
HSTM
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.
Last trade$27.74
Day change+$0.06 (+0.22%)
Day range$27.20 – $28.01
Volume91,847
Market cap$847M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$846.89M
Price / earnings
41.34×
Price / book
2.11×
Price / sales
2.58×
EV / sales
2.4×
EV / EBITDA
9.82×
Profitability
Earnings per share
$0.67
Return on assets
3.62%
Return on equity
5.1%
Dividend yield
0.47%
Liquidity and leverage
Debt / equity
0×
Current ratio
1.48×
Quick ratio
1.48×
Cash ratio
0.49×
Cash flow
Price / cash flow
11.9×
Price / free cash flow
13.57×
Free cash flow
$62.4M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for HSTM, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$83.31M
$83.73M
$81.2M
$79.71M
$76.47M
$74.4M
$73.49M
$74.24M
Cost of revenue
$30.01M
$29.02M
$27.76M
$28.85M
$26.51M
$26.36M
$25.49M
$25.11M
Gross profit
$53.3M
$54.72M
$53.45M
$50.86M
$49.97M
$48.03M
$48M
$49.12M
Selling, general and administrative
$21.92M
$21.54M
$20.96M
$22.66M
$19.47M
$19.21M
$20.82M
$21.29M
Research and development
$13.53M
$13.58M
$13.61M
$14.76M
$12.11M
$12.07M
$12.05M
$12.68M
Total operating expenses
$46.71M
$46.4M
$45.93M
$48.45M
$42.4M
$42.15M
$43.62M
$44.44M
Operating income
$6.59M
$8.32M
$7.51M
$2.4M
$7.57M
$5.89M
$4.38M
$4.69M
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
$7.07M
$8.7M
$7.82M
$2.85M
$8.25M
$6.87M
$5.25M
$5.48M
Income taxes
$1.7M
$2.03M
$1.91M
$317K
$2.17M
$1.48M
$916K
$594K
Net income
$5.37M
$6.67M
$5.91M
$2.53M
$6.09M
$5.39M
$4.33M
$4.89M
Net income attributable to common shareholders
$5.37M
$6.67M
$5.91M
$2.53M
$6.09M
$5.39M
$4.33M
$4.89M
EBITDA
$28.31M
$19.6M
$18.88M
$13.44M
$27.58M
$16.75M
$15.13M
$15.15M
Basic earnings per share
$0.18
$0.23
$0.20
$0.09
$0.20
$0.18
$0.14
$0.16
Diluted earnings per share
$0.18
$0.23
$0.20
$0.09
$0.20
$0.18
$0.14
$0.16
Recent news
Company coverage with links to the original publishers.
HealthStream (HSTM) has been upgraded to Zacks Rank #2 (Buy) due to upward trends in earnings estimates. The company, which provides internet-based educational and training content for healthcare professionals, has seen its Zacks Consensus Estimate increase 8.8% over the past three months. The upgrade positions the stock in the top 20% of Zacks-covered stocks, suggesting potential near-term price appreciation driven by improving business fundamentals.
HealthStream reported Q3 2026 earnings of $0.18 per share, beating consensus estimates of $0.15, with revenues of $83.31 million exceeding expectations by 1.28%. The stock has gained 46.1% year-to-date but received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions. Shopify is expected to report Q3 results on November 3 with projected earnings of $0.45 per share, representing 32.4% year-over-year growth.
HealthStream reported record quarterly revenue of $74.4 million, a 4.0% year-over-year increase, with strong performance in subscription services and platform-based solutions for healthcare workforce management.
Dropbox (DBX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.